.png){kind=icon}
.png){kind=icon}
Return
Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Locally Advanced Rectal Cancer: A Multicenter Propensity Score–Matched Study
.png){kind=icon}
PRE
AI
J
L
Y
Y
W
Q
P
Z
DOI：10.1097/DCR.0000000000003810.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Risk-adapted treatment strategies have been recommended for patients with rectal cancer. In our previous phase II study, neoadjuvant chemotherapy with capecitabine and oxaliplatin resulted in substantial tumor responses and encouraging survival outcomes for patients with locally advanced rectal cancer.
Keywords:
Disease-free survival
Metastasis-free survival
Neoadjuvant chemoradiotherapy
Neoadjuvant chemotherapy
Rectal cancer
Journal
D
IF:
3.7
Papers:
8.2K
Citations:
1.3W
Organization
Cited Papers